IIC Journal of Innovation 9th Edition | Page 140

Key Safety Challenges for the IIoT – Executive Summary network and remote analytics. Autonomy presents at least two safety challenges: system components, scaling the certification process is a challenge because the certification process is not oriented toward plug & play. For example, the current US Food and Drug Administration (FDA) regulatory process for medical devices has provisions to approve devices designed to work with other specific devices via the so- called accessory rule. 6 Each time a manufacturer (or set of manufacturers) wants to market a pair of medical devices composed into a new system, they need to create a new regulatory submission. However, in IIoT systems, the number of possible device combinations explodes exponentially with respect to the number of devices in the ecosystem. In general, pair- wise regulation is hugely burdensome for both the manufacturers and the regulatory agency. Each regulatory submission usually takes significant resources to prepare and review. 1. Autonomy changes how safety responsibility is divided between human operators and the system. 2. Sophisticated autonomy typically requires responding to dynamically changing circumstances and often involves the application of machine learning and artificial intelligence techniques that will themselves present verification challenges. To meet the first challenge, the stakeholders of autonomous IIoT systems must engage with one another and come to a consensus on which safety judgments and tradeoffs are appropriate for the autonomous system to make on its own. To meet the second challenge, the IIoT community must invest in research and development for verification of autonomous systems. To overcome existing regulatory burdens and help foster a large and vibrant IIoT ecosystem, industry and regulatory bodies should be prepared to move from system and pair-wise regulatory frameworks to approaches that scale with a larger number of interconnected components. An alternative is to have contract-based regulation, based on well-defined interfaces and behaviors of devices enabling the interfaces to be certified rather than the individual integrations. CHALLENGE 4: I NADEQUATE R EGULATORY F RAMEWORKS AND E VOLVING S TANDARDS One important desired capability of IIoT system components is plug & play interoperability. The goal of plug & play interoperability is to enable systems operators to assemble and integrate a new system for use quickly. For example, a medical provider could combine a set of medical sensors, actuators and control algorithms on the cloud to automate the delivery of certain therapies. Although plug & play should be possible for certified safety- 6 Medical Device Accessories – Describing Accessories and Classification Pathways - Guidance for Industry and Food and Drug Administration Staff, FDA-2015-D-0025, December 20, 2017, https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm429672.pdf September 2018 - 135 -